Literature DB >> 21048482

Comparison of depressive symptom severity scores in low-income women.

Shawn M Kneipp1, John A Kairalla, Jeanne Marie R Stacciarini, Deidre Pereira, M David Miller.   

Abstract

BACKGROUND: The Beck Depression Inventory, Second Edition (BDI-II), and the Patient Health Questionnaire-9 (PHQ-9) are considered reliable and valid for measuring depressive symptom severity and screening for a depressive disorder. Few studies have examined the convergent or divergent validity of these two measures, and none has been conducted among low-income women-although rates of depression in this group are extremely high. Moreover, variation in within-subject scores suggests that these measures may be less comparable in select subgroups.
OBJECTIVE: We sought to compare these two measures in terms of construct validity and to examine whether within-subject differences in depressive symptom severity scores could be accounted for by select characteristics in low-income women.
METHODS: In a sample of 308 low-income women, construct validity was assessed using a multitrait-monomethod matrix approach, between-instrument differences in continuous symptom severity scores were regressed on select characteristics using backward stepwise selection, and differences in depressive symptom classification were assessed using the Mantel-Haenszel test.
RESULTS: Convergent validity was high (rs = .80, p < .001). Among predictors that included age, race, education, number of chronic health conditions, history of depression, perceived stress, anxiety, and/or the number of generalized symptoms, none explained within-subject differences in depressive symptom scores between the BDI-II and the PHQ-9 (p > .05, R2 < .04). Similarly, there was consistency in depressive symptom classification (χ2 = 172 and 172.6, p < .0001). DISCUSSION: These findings demonstrate that the BDI-II and the PHQ-9 perform similarly among low-income women in terms of depressive symptom severity measurement and classifying levels of depressive symptoms, and do not vary across subgroups on the basis of select demographics.

Entities:  

Mesh:

Year:  2010        PMID: 21048482      PMCID: PMC3057908          DOI: 10.1097/NNR.0b013e3181f84ee9

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  36 in total

1.  Maximum likelihood analysis of logistic regression models with incomplete covariate data and auxiliary information.

Authors:  N J Horton; N M Laird
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

2.  Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.

Authors:  R C Arnau; M W Meagher; M P Norris; R Bramson
Journal:  Health Psychol       Date:  2001-03       Impact factor: 4.267

3.  Concordance between the PHQ-9 and the HSCL-20 in depressed primary care patients.

Authors:  Pamela W Lee; Herbert C Schulberg; Patrick J Raue; Kurt Kroenke
Journal:  J Affect Disord       Date:  2006-10-16       Impact factor: 4.839

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Use of the Beck Depression Inventory-II with depressed geriatric inpatients.

Authors:  R A Steer; D J Rissmiller; A T Beck
Journal:  Behav Res Ther       Date:  2000-03

7.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

8.  The utility of the Beck Depression Inventory Fast Screen (BDI-FS) in a pain clinic population.

Authors:  Helen Poole; Ros Bramwell; Peter Murphy
Journal:  Eur J Pain       Date:  2008-11-14       Impact factor: 3.931

9.  Psychosocial and physiological stress among women leaving welfare.

Authors:  Shawn M Kneipp; Dinah P Welch; Charles E Wood; Carolyn B Yucha; Hossein Yarandi
Journal:  West J Nurs Res       Date:  2007-07-13       Impact factor: 1.967

10.  Assessment of the PHQ-9 as a screening tool for depression in patients with chronic hepatitis C.

Authors:  Nader Dbouk; Miguel R Arguedas; Aasim Sheikh
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more
  6 in total

1.  Screening for and preventing perinatal depression.

Authors:  Bonnie D Kerker; Judy A Greene; Rachel Gerson; Michele Pollock; Kimberly E Hoagwood; Sarah McCue Horwitz
Journal:  J Child Fam Stud       Date:  2018-06-20

2.  Mood Influences the Perception of the Sitting Affordance.

Authors:  Colin Vegas; Éric Laurent
Journal:  Atten Percept Psychophys       Date:  2021-12-14       Impact factor: 2.199

3.  Comparing the Beck Depression Inventory-II (BDI-II) and Patient Health Questionnaire (PHQ-9) Depression Measures in an Outpatient Bariatric Clinic.

Authors:  Paul E Schutt; Simon Kung; Matthew M Clark; Afton M Koball; Karen B Grothe
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

4.  Validation and calibration of the patient health questionnaire (PHQ-9) in Argentina.

Authors:  María Urtasun; Federico Manuel Daray; Germán Leandro Teti; Fernando Coppolillo; Gabriela Herlax; Guillermo Saba; Adolfo Rubinstein; Ricardo Araya; Vilma Irazola
Journal:  BMC Psychiatry       Date:  2019-09-18       Impact factor: 3.630

5.  Symptom prevalence differences of depression as measured by BDI and PHQ scales in the Look AHEAD study.

Authors:  Elizabeth M Vaughan; Craig A Johnston; Jennette P Moreno; Lawrence J Cheskin; Gareth R Dutton; Molly Gee; Sarah A Gaussoin; William C Knowler; W Jack Rejeski; Thomas A Wadden; Susan Z Yanovski; John P Foreyt
Journal:  Obes Sci Pract       Date:  2019-12-19

6.  Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial.

Authors:  Maria Antonietta Nettis; Giulia Lombardo; Caitlin Hastings; Zuzanna Zajkowska; Nicole Mariani; Naghmeh Nikkheslat; Courtney Worrell; Daniela Enache; Anna McLaughlin; Melisa Kose; Luca Sforzini; Anna Bogdanova; Anthony Cleare; Allan H Young; Carmine M Pariante; Valeria Mondelli
Journal:  Neuropsychopharmacology       Date:  2021-01-28       Impact factor: 8.294

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.